256: Explaining the E.U.'s pharma overhaul, Lilly's booming business, & a long-awaited drug approval

Andrew Joseph, STAT's Europe correspondent, joins us to explain the EU's sweeping proposal to overhaul how new drugs are regulated on the continent — and why the pharmaceutical industry is fighting it. We also discuss the latest news in the life sciences, including Lilly's surging business, a pair of new drug approvals, and a novel idea in Alzheimer's disease.

Episode metadata supplied by the publisher feed · Published Apr 27, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

256: Explaining the E.U.'s pharma overhaul, Lilly's booming business, & a long-awaited drug approval

0:00 28:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 28 minutes long.

When was this The Readout Loud episode published?

This episode was published on April 27, 2023.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!